US drug authority approves world’s initially extended-performing HIV regimen
GlaxoSmithKline (GSK.L) announced its ViiV Healthcare arm has acquired acceptance from the US Meals and Drug Administration (Fda) for Cabenuva,...
GlaxoSmithKline (GSK.L) announced its ViiV Healthcare arm has acquired acceptance from the US Meals and Drug Administration (Fda) for Cabenuva,...
